Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia. (Q53051177)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

object named as

Serenoa repens

1 reference

based on heuristic

inferred from title

author name string

Ioanel Sinescu

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Petrisor Geavlete

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Razvan Multescu

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Constantin Gangu

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Florin Miclea

5

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Ioan Coman

6

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Ioan Ioiart

7

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Valentin Ambert

8

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Traian Constantin

9

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Bogdan Petrut

10

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Bogdan Feciche

11

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

publication date

8 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Urologia Internationalis

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

86

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

284-289

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Serenoa repens (saw palmetto): a systematic review of adverse events

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

A detailed safety assessment of a saw palmetto extract

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Impact of medical treatments for benign prostatic hyperplasia on sexual function

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Saw palmetto for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1159%2F000322645

21 January 2018

Identifiers

10.1159/000322645

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/21304222

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53051177&oldid=1610913026"